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Abstract Low Mr phosphotyrosine protein phosphatase (PTP)
is a cytosolic enzyme whose activity upon platelet-derived growth
factor (PDGF) and insulin receptors has been demonstrated in
vivo. In our study we demonstrate that this enzyme, both
naturally expressed and overexpressed in NIH/3T3 fibroblasts,
translocates from the cytosol to the Triton X-100 insoluble
fraction following stimulation with PDGF. It emerges that the
phosphorylation of a defined population of PDGF receptors,
which is localized in this fraction and seems to be endowed with
peculiar features and functions, is particularly affected by low
Mr PTP overexpression.
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1. Introduction
Tyrosine phosphorylation of speci¢c cellular proteins is a
crucial mechanism typical of those pathways involved in the
transmission of signals from a large variety of stimuli. Phos-
photyrosine protein phosphatases (PTPs) together with phos-
photyrosine protein kinases regulate tyrosine phosphoryla-
tion.
Low Mr PTP is a cytosolic enzyme [1] which exists in two
isoenzymatic forms. While nothing is known regarding the
physiological role of the ¢rst isoform (also named ‘fast’),
more and more details are emerging concerning the second
(‘slow’), which is the subject of this study. This isoenzyme
seems to be rather ubiquitous since it was detected in liver,
brain, ¢broblasts, placenta, heart and erythrocytes from dif-
ferent species [2^7]. It possesses the characteristic PTP homol-
ogy domain CXXXXXR in its active site and its phosphate
binding loop shows three-dimensional identity with that con-
tained in PTP1B and Yersinia PTP, as is apparent from the
resolved crystal structure of the enzyme [8]. Nevertheless it
does not share any sequence homology with the other mem-
bers of the non-receptor cytosolic phosphotyrosine phospha-
tase subfamily. In particular, this enzyme does not show any
of the structural features which usually mediate stable or tem-
porary association of PTPs with the particulate fraction as
SH2 domains, myristoylation sites or cytoskeletal protein-
like domains [9]. However, its ability to act upon membrane
substrates has already been demonstrated: ¢rst its activity
upon epidermal growth factor receptor (EGFr) was evidenced
in vitro [10], subsequently the overexpressed enzyme displayed
a phosphatase activity upon platelet-derived growth factor
receptor (PDGFr) [4] and insulin receptor [11] in NIH/3T3
cells.
Low Mr PTP seems to be regulated by Src-kinase, in fact it
is phosphorylated and activated by the oncogenic variant
pp60vÿsrc [12,13]. This evidence further supports its integra-
tion in a complex of molecular interactions which take place
in the particulate fraction.
Several so-called cytosolic PTPs are known to translocate to
the particulate fraction following growth factor stimulation or
cell transformation: for example PTP1D interacts with acti-
vated EGFr and PDGFr via its SH2 domains [14,15] ; PTP1 is
localized to focal adhesions as well as to the endoplasmic
reticulum of Src-transformed ¢broblasts, through its car-
boxy-terminal hydrophobic tail [16]. In these cases such PTP
redistribution could participate in the de¢nition of their sub-
strate speci¢city.
It is well known that PDGFr is localized in cell membrane
(Triton X-100 soluble fraction). Recently Coats et al. demon-
strated that a sub-population of PDGFr is distributed in a
Triton X-100 insoluble fraction and it colocalizes with several
cytoskeletal proteins [17]. Here we demonstrate that low Mr
PTP (both naturally expressed and overexpressed) exclusively
undergoes a translocation from the cytosol to this Triton in-
soluble fraction following PDGF stimulation. We show a
greater and more speci¢c decrease in tyrosine phosphorylation
of Triton insoluble than Triton soluble PDGFrs when low Mr
PTP is overexpressed. These results allow us to hypothesize
the involvement of such translocation in the determination of
low Mr PTP substrate choice.
2. Materials and methods
2.1. Cell culture and transfection
NIH/3T3 murine ¢broblasts (normal or v-src transformed) came
from the Laboratory of Cellular and Molecular Biology of the NCI,
National Institutes of Health, Bethesda, MD, USA and were cultured
in Dulbecco’s modi¢ed Eagle’s medium containing 4.5 g/l glucose,
supplemented with 10% fetal calf serum (FCS) (complete medium).
All cells were cultured in a humidi¢ed atmosphere of 5% CO2 at 37‡C.
Normal and v-src transformed NIH/3T3 overexpressing low Mr
PTP were previously obtained in our laboratory through cotransfec-
tion of pSVPTP and pK0neo plasmids [18,19].
In order to obtain c-src overexpressing cells, control (neomycin
resistant) and PTP overexpressing NIH/3T3 were cotransfected with
8 Wg of pSGT plasmid, containing the cDNA coding for pp60cÿsrc
(obtained from Sara Courtneidge, EMBL, Heidelberg, Germany [20]),
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and 1 Wg of pBABEpuro plasmid, carrying the resistance to puromy-
cin [21], in a 60-mm Petri dish, using the calcium phosphate precip-
itation technique. Control cells were obtained with transfection of
pBABEpuro plasmid only. Stable puromycin resistant clones were
isolated by supplementing medium with 2 Wg/ml antibiotic.
In order to maintain stable expression all transfected cell lines were
periodically cultured in selective medium.
2.2. Evaluation of pp60cÿsrc overexpression
In order to individuate c-src overexpressing clones, cells were col-
lected in Laemmli sample bu¡er, boiled for 10 min and centrifuged at
10 620Ug for 10 min. Equal protein amounts from the lysates were
subjected to 12% SDS-polyacrylamide gel electrophoresis (SDS-
PAGE), Western blot and immunorecognition with monoclonal 327
anti-pp60src antibody followed by incubation with peroxidase-conju-
gated anti-mouse antibody (Transduction Laboratories) and ECL de-
tection (Amersham).
The activity of the enzyme was veri¢ed following its immunopreci-
pitation. Cells (both control and Src overexpressing) were lysed in
hypotonic bu¡er (10 mM HEPES, pH 7.5, 10 mM NaCl, 1 mM
KH2PO4, 5 mM NaHCO3, 1 mM CaCl2, 0.5 mM MgCl2, 5 mM
EDTA, 1 mM sodium vanadate, 20 mM NaF, 10 mM sodium pyro-
phosphate, 10 Wg/ml leupeptin, 20 Wg/ml aprotinin, 1 mM PMSF)
supplemented with 1% Triton X-100. The lysate was centrifuged at
100 000Ug for 30 min, then the kinase was immunoprecipitated by
adding 15 Wg of anti-Src antibodies and 35 Wl of protein G-Sepharose
(Pharmacia). Following washes, the resin-bound kinase was assayed
on Raytide peptide (Oncogene) in the presence of [Q-32P]ATP follow-
ing the manufacturer’s instructions. The reaction products, adsorbed
on phosphocellulose, were analyzed by liquid scintillation counting
and revealed the presence of active overexpressed Src-kinase.
2.3. Stimulation of cells with mitogens
Cells were grown to sub-con£uence, then they were serum starved
for 24 h and stimulated with 20 ng/ml PDGF-BB (Peprotech) for the
indicated time periods at 37‡C. To stop growth factor stimulation
dishes were placed on ice and rapidly washed twice with ice-cold
phosphate-bu¡ered saline (PBS) (10 mM Na2HPO4, 150 mM NaCl,
pH 7.4) supplemented with 100 WM sodium vanadate.
2.4. Cell fractionation
Cell fractionation was performed according to Oude Weernink et
al. [22] with minor modi¢cations. Cells from a sub-con£uent 10-mm
dish were collected in 500 Wl hypotonic bu¡er and sonicated twice for
15 s in ice. Cell debris was removed from the lysate by centrifugation
at 1000Ug for 3 min and then the lysate was centrifuged at
100 000Ug for 30 min at 4‡C; the resulting supernatant represented
the cytosolic fraction.
The pellet was washed twice with hypotonic bu¡er, then it was
extracted for 30 min in ice with 30 Wl of the same bu¡er supplemented
with 1% Triton X-100 and centrifuged at 100 000Ug for 30 min. The
Triton X-100 soluble supernatant was supplemented with Laemmli
sample bu¡er and boiled.
The residual Triton X-100 resistant material was washed twice with
1% Triton and further solubilized in 30 Wl of RIPA bu¡er (50 mM
Tris-HCl, pH 8.0, 150 mM NaCl, 1% Nonidet P40, 0.1% SDS, 0.5%
sodium deoxycholate, 1 mM sodium vanadate, 20 mM NaF, 10 mM
sodium pyrophosphate, 10 Wg/ml leupeptin, 20 Wg/ml aprotinin, 1 mM
PMSF) for 30 min in ice, then 15 Wl of boiling 3ULaemmli sample
bu¡er was added (¢nal SDS concentration: 2.1%). This fraction, re-
ferred to as Triton insoluble fraction, was clari¢ed through centrifu-
gation at 10 620Ug for 10 min.
2.5. Low Mr PTP immunoprecipitation
The detection of low Mr PTP in the cytosol was rather di⁄cult due
to the large volume of this fraction (500 Wl). For this reason the
enzyme was immunoprecipitated by incubating for 3 h in ice with
5 Wg polyclonal anti-low Mr PTP antibodies, which had been raised
in rabbits and a⁄nity puri¢ed as previously described [23]. We veri¢ed
that the amount of antibody used was enough to completely clear a
lysate from the enzyme. The immunoprecipitate was recovered upon
addition of 5 Wl protein A-Sepharose (SIGMA), during 1 h of incu-
bation in a shaker at 4‡C. The resin bound complex was washed three
times with PBS and then it was eluted with boiling 2ULaemmli sam-
ple bu¡er. When we analyzed the PTP distribution during the time
course of PDGF stimulation, samples from each time point contain-
ing equal protein amounts were subjected to immunoprecipitation.
2.6. Western blotting analysis
In order to determine the PTP distribution the immunoprecipitate
from the cytosol as well as aliquots of 20 Wg of proteins from Triton
soluble and insoluble fractions were subjected to SDS-PAGE and
immunoblotting with peroxidase-conjugated speci¢c antibodies. The
immunoreactive bands were visualized by ECL (Amersham) detection
on a Biomax Light ¢lm (Kodak). In order to evidence the endogenous
enzyme the detection was performed using the highly sensitive ECL
plus.
The various fractions were sometimes analyzed also for the presence
of pp60src (using 327 mAb antibodies as cited above) and PDGF
receptor (using polyclonal anti-PDGFr, Santa Cruz, and peroxidase-
conjugated anti-rabbit, Calbiochem). Their tyrosine phosphorylation
pattern was determined using RC20 peroxidase-conjugated anti-phos-
photyrosine antibodies (Transduction Laboratories).
Successive immunorecognitions were performed on the same nitro-
cellulose membrane following the stripping procedure described by the
manufacturer for the ECL detection method.
A densitometric analysis of bands was performed.
3. Results
NIH/3T3 ¢broblasts were stimulated with PDGF-BB for
increasing time periods, cell lysates were then subjected to
fractionation. Low Mr PTP was immunoprecipitated from
the cytosolic fraction while, in the case of Triton soluble
and insoluble fractions, which had a much lower volume (45
Wl), it was not necessary to recover the enzyme through im-
munoprecipitation.
The immunoblot analysis of fractions with anti-PTP anti-
bodies, following the electrophoretic separation of bands,
showed a gradual reduction in the amount of the cytosolic
enzyme and a subsequent return to the basal level during
growth factor stimulation (Fig. 1). This time course was ac-
companied by a complementary variation in the PTP level in
the Triton insoluble fraction. From the densitometric analysis
of bands it emerges that, at 10 min stimulation, about 50% of
the enzyme moved from the cytosol to the Triton X-100 in-
soluble fraction. At these time points of stimulation no en-
zyme could be detected in the Triton soluble fraction.
Until now all observations of low Mr PTP activity in vivo
had been performed on overexpressed enzyme, particularly we
were able to evidence its e¡ect upon PDGFr phosphorylation
comparing control and PTP overexpressing cells [4]. We then
decided to verify if also the overexpressed enzyme was sub-
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Fig. 1. Low Mr PTP translocation in NIH/3T3 ¢broblasts. Frac-
tions obtained from cells stimulated with PDGF-BB were subjected
to 12% SDS-PAGE and immunoblotting with anti-PTP antibodies
conjugated to peroxidase, followed by ECL-plus detection. A: Im-
munoprecipitates obtained with anti-PTP antibodies from the cyto-
solic fraction. B: Triton X-100 insoluble fraction. Lane 1: unstimu-
lated; lane 2: 5 min stimulation; lane 3: 10 min stimulation; lane
4: 20 min stimulation; lane 5: 30 min stimulation.
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jected to such a translocation following PDGF stimulation.
The analysis of low Mr PTP overexpressing NIH/3T3 revealed
a time course of migration from the cytosol to the Triton
insoluble fraction practically identical to that typical of the
naturally expressed enzyme.
The translocation of the PTP to the Triton X-100 insoluble
fraction was very interesting. In fact, given the abundant dis-
tribution of PDGFrs in the Triton soluble fraction (which can
be identi¢ed with the membrane) one could expect to observe
a movement of low Mr PTP in this compartment. Recently
Coats et al. [17] demonstrated that a well de¢ned pool of
PDGFr resides in a Triton insoluble fraction which codistrib-
utes with cytoskeleton. Taking into account this observation
we decided to verify the phosphorylation state of PDGFr in
Triton X-100 soluble and insoluble fractions from control and
PTP overexpressing cells. Cells were stimulated for 10 min
with PDGF, fractions were then obtained and analyzed
through 10% SDS-PAGE, Western blot and immunorecogni-
tion with anti-phosphotyrosine antibodies. Fig. 2B shows a
decrease in the staining of phosphorylated PDGFr band in
NIH/3T3-PTP compared to control cells. It is noteworthy
that, as regards the Triton soluble fraction, besides a 54.3%
decrease (from the densitometric analysis of bands) in PDGFr
staining there is a general decrease in the tyrosine phospho-
rylation level of various proteins in NIH/3T3-PTP compared
to control cells. This does not happen in the Triton insoluble
fraction where the reduction in the phosphorylation level per-
tains essentially to PDGFr band (372%). An equivalent
amount of receptor was present in the compared lanes (Fig.
2A). In Fig. 2C we verify that, at this time point of stimula-
tion (10 min) overexpressed low Mr PTP e¡ectively translo-
cated from the cytosol to the Triton insoluble fraction.
v-src transformed NIH/3T3 grow in the absence of growth
factors and if they are stimulated with PDGF-BB neither
phosphorylation of the speci¢c receptor nor an increase in
the mitogenic rate can be observed [12]. In fact Zhang et al.
demonstrated a reduction in PDGFr mRNA in v-src trans-
formed NRK ¢broblasts [24]. The analysis of overexpressed
low Mr PTP distribution in v-src NIH/3T3 showed that it is
abundantly represented in the Triton insoluble fraction (Fig.
3A), besides being present in the cytosol. Considering that
only 1/9 of the Triton insoluble fraction was subjected to
electrophoresis, while the immunoprecipitate from the cytosol
was entirely applied to the gel, we evaluate that about 68%
was present in the former fraction and 32% in the latter (den-
sitometric analysis). Traces of the enzyme can be detected in
the Triton soluble fraction too, but we think that they should
be considered a contamination of the preparation, given the
large amount of overexpressed PTP in this cell line. Following
stripping of this nitrocellulose ¢lter and incubation with anti-
phosphotyrosine antibodies we noticed that low Mr PTP was
tyrosine-phosphorylated both when present in the cytosol and
in the Triton insoluble fraction (Fig. 3B), though to di¡erent
extents: 44% in the former and 113% in the latter fraction, as
revealed by the densitometric analysis.
pp60cÿsrc is known to migrate from membrane to cytoskel-
eton (and precisely to focal adhesions) during PDGF stimu-
lation [23], while pp60vÿsrc is permanently localized in focal
adhesions [25]. We then decided to verify if there could be a
cofractionation of low Mr PTP and pp60cÿsrc and a temporal
coincidence in their translocation. Cells overexpressing both
the PTP and the kinase were stimulated with PDGF for 10
min, lysates were obtained in hypotonic bu¡er and then sub-
jected to fractionation. The various fractions were examined
through electrophoresis and Western blotting with both anti-
PTP and anti-Src antibodies. Fig. 4B reveals the expected
migration of a part of the cytosolic PTP to the Triton insolu-
ble fraction during growth factor stimulation. In lane 7 we
analyze a control lysate which was completely cleared of PTP
using 5 Wl of the speci¢c antibody. In Fig. 4A, which was
obtained through stripping and re-probing of the same nitro-
cellulose ¢lter, we can appreciate the concomitant transloca-
tion of a certain amount of c-src from the Triton soluble to
the insoluble fraction. The two bands which stain positive in
Fig. 4A, lanes 1 and 2 (corresponding to the cytosol, where
Src-kinase is not localized), represent a cross-reaction of the
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Fig. 3. Low Mr PTP distribution and tyrosine phosphorylation in v-
src transformed NIH/3T3. Cell lysates were subjected to fractiona-
tion followed by 12% SDS-PAGE and Western blot. A: Immuno-
recognition with anti-PTP antibodies. B: Immunorecognition with
anti-phosphotyrosine antibodies. Lane 1: immunoprecipitate with
anti-PTP antibodies from the cytosol; lane 2: control immunopre-
cipitate with non-speci¢c immunoglobulins; lane 3: Triton X-100
soluble fraction; lane 4: Triton X-100 insoluble fraction; lane 5:
standard low Mr PTP.
Fig. 2. PDGFr tyrosine phosphorylation in control and PTP overex-
pressing NIH/3T3. Cells were stimulated with PDGF-BB for 10
min. Fractions were subjected to SDS-PAGE, Western blotting and
ECL detection. A: Immunorecognition of PDGFr band, performed
with anti-PDGFr antibodies and peroxidase-conjugated anti-rabbit,
showing PDGFr content in lanes of panel B. B: Tyrosine phospho-
rylation pattern, obtained with peroxidase-conjugated anti-phospho-
tyrosine antibodies. Lanes 1^4: Triton X-100 soluble fractions; lanes
5^8: Triton X-100 insoluble fractions; lanes 1, 2, 5, 6: control
NIH/3T3; lanes 3, 4, 7, 8: PTP overexpressing NIH/3T3. Arrow:
PDGF receptor. C: Low Mr PTP distribution in PTP overexpress-
ing cells, obtained with peroxidase-conjugated speci¢c antibodies.
Lanes 1, 2: immunoprecipitates obtained with anti-PTP antibodies
from the cytosol; lanes 3, 4: Triton insoluble fraction.
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rabbit immunoglobulins used to immunoprecipitate low Mr
PTP with the anti-mouse used as secondary conjugated anti-
body in this blot.
It can be seen that the PTP band is double, which may
indicate that the enzyme is subjected to some modi¢cation
in certain conditions (i.e. during Src overexpression). By re-
probing this ¢lter with anti-phosphotyrosine antibodies we
veri¢ed that the modi¢cation responsible for this variation
in electrophoretic mobility does not consist in tyrosine phos-
phorylation. Further investigation is needed to clarify this
evidence.
4. Discussion
Low Mr PTP structurally belongs to the cytosolic PTP sub-
family, nevertheless so far it has been shown to interact only
with proteins which are localized in the particulate fraction: it
dephosphorylates PDGFr [4] and insulin receptor [16] and it is
phosphorylated and activated by pp60vÿsrc [12,13].
We decided to verify if this enzyme could undergo a trans-
location from the cytosol to the particulate fraction where it
performs its enzymatic activity. The analysis of the PTP dis-
tribution revealed that it moves, during the time course of
PDGF stimulation, from the cytosol to the Triton X-100 in-
soluble fraction and then again to the cytosol as we prolonged
growth factor stimulation. It is noteworthy that the enzyme is
present, though at a low level, in the Triton insoluble fraction
of unstimulated cells too.
Interestingly, we were able to evidence this translocation
also in not overexpressing cells : this is the ¢rst evidence of
the enzyme which is normally expressed in NIH/3T3 cells and
it sustains all our previous lines of evidence which had been
obtained through its overexpression, corroborating the thesis
of a physiological (not pharmacological) role of this enzyme
on PDGF signaling in vivo.
The analysis of the tyrosine phosphorylation pattern fol-
lowing growth factor addition shows that PDGFr is more
dephosphorylated in the Triton X-100 insoluble than in the
Triton X-100 soluble fraction of PTP overexpressing cells
compared to control NIH/3T3 (Fig. 2). This e¡ect seems to
be more speci¢c too, in fact there is a general phosphorylation
decrease in the Triton soluble fraction of PTP overexpressing
cells compared to controls, while only the phosphorylation of
the PDGFr band is a¡ected in the Triton insoluble fraction by
PTP overexpression, at this time point of stimulation. Recent
research indicates that several growth factor receptors can
concentrate in speci¢c regions where the plasma membrane
interacts with the cytoskeleton to give specialized structures:
for example, it has been reported that activated PDGFr
moves in membrane ru¥es [26] or in caveolae [27]. Finally
it has become evident that a distinct subset of cellular PDGFr
is present in a Triton X-100 insoluble fraction. Coats et al.
[19] demonstrated that this sub-population of receptors is
characterized by peculiar properties and functions such as
higher basal tyrosine phosphorylation state, resistance to
downregulation, cofractionation with cytoskeletal proteins
and increased abundance with increasing cell density. They
hypothesized that this receptor pool could be speci¢cally in-
volved in long-term responses to growth factor stimulation in
those cellular modi¢cations which involve a cytoskeletal rear-
rangement (such as membrane ru¥ing and chemotaxis). Our
results raise the possibility of a regulatory role of low Mr PTP
on this distinct pool of PDGFr.
We could distinguish between a PTP activity upon PDGFr
which is linked to its translocation in the same fraction (the
Triton insoluble one) where this pool of receptors resides, and
an activity on Triton soluble PDGFrs, which is not accom-
panied by PTP redistribution. We may argue that the former
activity is more speci¢c, while the latter could be a pharma-
cological e¡ect of low Mr PTP overexpression. The general
reduction in tyrosine phosphorylation which we observed in
the Triton soluble fraction could also re£ect the decrease in
PDGFr kinase activity once it is dephosphorylated by the
PTP.
Some preliminary lines of evidence point to a possible role
of pp60src in low Mr PTP movement: in v-src transformed
NIH/3T3 the overexpressed PTP is abundantly distributed in
the Triton insoluble fraction, where the oncogenic kinase is
known to be prevalently localized too. It is important to note
that, given the unresponsiveness of this cell line to PDGF, we
can exclude the involvement of those proteins which are re-
cruited independently of Src by PDGFr in mediating the lo-
calization of the PTP.
The observation of the coincidence (at least for the time
point which is considered in this experiment, Fig. 4) in the
translocation of pp60cÿsrc and low Mr PTP to the Triton
insoluble fraction during PDGF stimulation gives a basis
for a hypothesis regarding a possible connection between
the movements of the two enzymes. This colocalization is
also an indirect con¢rmation of the goodness of our fraction-
ation technique, since c-src redistribution during PDGF
stimulation is a well known event.
As regards any hypothesis regarding the translocation
mechanism and the role of pp60src in it, for the moment we
can only say that there does not seem to be a strict correlation
between PTP localization and its tyrosine phosphorylation. In
fact, as can be appreciated from Fig. 3B, in v-src transformed
cells the enzyme is phosphorylated both in the cytosol and in
the Triton insoluble fraction, while in normal and c-src over-
expressing ¢broblasts it is not phosphorylated in either of the
two fractions (data not shown). We cannot exclude that, in
this latter case, we failed to detect low Mr PTP phosphoryla-
tion due to its ability to auto-dephosphorylate and to the
di⁄culty of completely inhibiting its activity. At any case,
the possible loss of phosphorylation did not abrogate the
enzyme redistribution.
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Fig. 4. Low Mr PTP and pp60cÿsrc translocation during PDGF
stimulation. NIH/3T3 overexpressing both low Mr PTP and
pp60cÿsrc were stimulated with PDGF-BB for 10 min. Fractions
were then analyzed through 12% SDS-PAGE and immunoblotting
followed by ECL detection. A: Immunorecognition with anti-src
antibodies and peroxidase-conjugated anti-mouse. B: Immunorecog-
nition with peroxidase-conjugated anti-PTP antibodies. Lanes 1, 2:
immunoprecipitates obtained from the cytosol with anti-PTP anti-
bodies; lanes 3, 4: Triton X-100 soluble fraction; lanes 5, 6: Triton
X-100 insoluble fraction; lane 7: lysate deprived of low Mr PTP;
lane 8: standard low Mr PTP.
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Our current research is oriented to the identi¢cation of the
precise site of low Mr PTP translocation, in particular we
want to verify if this coincides with focal adhesions where
Src kinase migrates following growth factor stimulation
[28,29], also considering the reported cofractionation of the
Triton insoluble pool of PDGFr with vimentin and focal ad-
hesion kinase [17]. Structural features underlying this redis-
tribution are under investigation.
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